| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO | President And CEO
1 company
Crockett Thomas Andrew is a CEO at KalVista Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 16, 2020 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 1,261 | $17.01 | $21,444.06 | -0.5% | |
| Feb 5, 2020 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 200 | $17.05 | $3,410.00 | - | |
| Dec 20, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 2,300 | $17.02 | $39,150.37 | -1.0% | |
| Dec 16, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 7,700 | $17.06 | $131,352.30 | -1.0% | |
| Jul 15, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $17.04 | $170,407.00 | -3.9% | |
| Apr 15, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $24.80 | $247,957.72 | -1.9% | |
| Mar 14, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 3,000 | $30.16 | $90,483.90 | -1.1% | |
| Jan 14, 2019 | KALV Kalvista Pharmaceuticals, Inc. | CEO | Sell | 10,000 | $19.33 | $193,328.29 | -1.8% |